CAS 944258-89-3

Simotinib

CAS: 944258-89-3

Simotinib

Purity: ≥98%

Molecular weight: 500.95g/mol

Ref: 54-BUP21811

Simotinib

CAS: 944258-89-3

Simotinib is a kinase inhibitor that has shown promising results in the treatment of various types of cancer. It targets specific proteins that are involved in the growth and survival of tumor cells, leading to apoptosis (cell death) and inhibition of cancer cell proliferation. This medicinal compound is an analog of cyclin-dependent kinases inhibitors and has been extensively studied in Chinese patients with lung cancer. Simotinib works by blocking the activity of certain enzymes that promote tumor growth, making it an effective anticancer agent. It has also been found to have potential therapeutic applications in other types of cancer, including breast and prostate cancer. Overall, Simotinib shows great promise as a targeted therapy for cancer treatment.

Formula: C₂₅H₂₆ClFN₄O₄

Purity: Min. 95%

Molecular weight: 500.9 g/mol

Ref: 3D-UMB25889

Simotinib

CAS: 944258-89-3

Simotinib (AL-6802) is an EGFR tyrosine kinase inhibitor (IC50 : 19.9 nM) with antitumour activity for the study of non-small cell lung cancer.

Formula: C₂₅H₂₆ClFN₄O₄

Purity: 99.7%

Color and Shape: Solid

Molecular weight: 500.95

Ref: TM-T35916